Cegedim EBIT per Share
The EBIT per Share of Cegedim (ALCGM.PA) as of Aug 5, 2026 is 2.20 EUR. In the previous year, EBIT per Share was 0.81 EUR — a change of 171.32% (higher).
Get this data via API
Financial Data API
EBIT per Share
2.20EUR
YoY
171.32%
Last updated:
EBIT per Share of Cegedim is 2026 2.20 EUR. EBIT per Share of Cegedim was 2025 0.81 EUR. It decreases by 171.32% higher compared to the previous year.
Access this data via the Eulerpool API
Cegedim Stock analysis
What does Cegedim do? Cegedim SA is a French company that was founded in 1969. It has since become one of the leading providers of IT solutions for the healthcare industry worldwide. Headquartered in Boulogne-Billancourt, France, the company operates in over 80 countries and employs over 4,000 employees.
The business model of Cegedim is focused on improving the efficiency and effectiveness of healthcare providers. To do this, the company offers a wide range of products and services based on IT solutions and digital technologies. These are designed to help doctors, pharmacists, hospitals, insurance companies, and other stakeholders in the healthcare industry improve their workflows and optimize patient care.
One of the company's key divisions is the Cegedim Health Data Division, which specializes in the collection, analysis, and processing of health data. This includes databases and analyses of medication prescriptions and medical care pathways. This information provides valuable insights into the market and helps healthcare providers identify trends.
In addition, Cegedim offers a wide range of IT solutions for the healthcare industry, including e-health platforms, medical practice software, electronic patient records, and insurance billing systems.
One of Cegedim's particular strengths is its experience in data analysis. The company has a broad expertise and years of experience in this field. An example of this is the Cegedim IRIS Index, which enables healthcare providers to assess the effectiveness of their medical care. This tool provides cost-optimized and patient-centered analysis and is, therefore, an important part of the Cegedim product line.
Cegedim also works closely with health authorities, hospitals, universities, and other stakeholders to develop innovative ideas and solutions. The company is a member of numerous industry organizations, including the European Health Telematics Association (EHTEL) and the Healthcare Information and Management Systems Society (HIMSS).
Cegedim's product range is diverse to meet the different needs of healthcare providers. These include:
- PMD, a medical practice software that enables efficient management of practice processes and patient data.
- Mobile Health Solutions, which allows doctors and nurses to access patient data and medical information from mobile devices.
- Medication Insights, a tool for analyzing medication prescriptions that provides valuable insights into the market for healthcare providers and pharmaceutical companies.
Cegedim also relies on strategic partnerships to improve the reach and performance of its products and services. One example of this is the partnership with Salesforce, which leads to the development of joint solutions to support doctors and other healthcare professionals.
Overall, Cegedim has established itself as one of the leading companies in the healthcare industry, leveraging innovative technologies and data analysis to help its customers work more effectively and efficiently. Cegedim is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Cegedim stock
EBIT per Share of Cegedim is 2.20 EUR in 2026.
EBIT per Share of Cegedim changed from 0.81 EUR to 2.20 EUR, representing a 171.32% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Cegedim since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Cegedim
All Key Metrics — Cegedim
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth